文献速递功能神经外科

立体定向框架式术中MRI引导与验证脑深部电刺激的准确性、精确性和安全性:650例连续手术分析

Accuracy, precision, and safety of stereotactic, frame-based, intraoperative MRI-guided and MRI-verified deep brain stimulation in 650 consecutive procedures.
PubMed 文献 · J Neurosurg · 2022-10-28

该回顾性分析纳入650例连续立体定向框架式脑深部电刺激(DBS)手术,利用术中MRI引导并验证电极置入。最终靶点误差为0.9±0.3 mm,97%电极单次穿刺即达解剖可接受位置,出血发生率0.6%,无MRI相关并发症、永久性运动障碍或死亡。多通道穿刺时出血率显著高于首次穿刺。

要点

  • 最终靶点误差平均0.9±0.3 mm,97%电极单次穿刺即达解剖可接受位置。
  • 出血发生率0.6%,多通道穿刺出血率5.4% vs 首次穿刺0.2%(P=0.0058)。
  • 无MRI相关并发症、永久性运动障碍或死亡。

核心结论

  • 术中MRI引导并验证DBS电极位置具有高准确性、精确性和安全性,多通道穿刺时出血率显著增高但未导致永久性功能障碍。

研究设计与样本

  • 回顾性分析650例连续立体定向框架式DBS手术,在配备MRI的手术室中进行,术后立即验证电极位置。

主要发现

  • 1201根电极中,643例手术用立体定向MRI验证,7例用立体定向CT验证。
  • 最终靶点误差平均0.9±0.3 mm(范围0.1-2.3 mm)。
  • 97%(n=1164)电极单次穿刺即达解剖可接受位置,37根电极(3%)需术中立即重新定位。
  • 出血4例(0.6%),其中立即重新定位者2/37根(5.4%) vs 首次穿刺者2/1164根(0.2%)(P=0.0058)。
  • 感染21例(3.2%手术,3个月内1.5%),导致硬件取出;6根电极(0.5%)在4例患者(0.6%手术)中因刺激效果欠佳于3个月后重新靶向。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Suboptimal lead placement is one of the most common indications for deep brain stimulation (DBS) revision procedures. Confirming lead placement in relation to the visible anatomical target with dedicated stereotactic imaging before terminating the procedure can mitigate this risk. In this study, the authors examined the accuracy, precision, and safety of intraoperative MRI (iMRI) to both guide and verify lead placement during frame-based stereotactic surgery. METHODS: A retrospective analysis of 650 consecutive DBS procedures for targeting accuracy, precision, and perioperative complications was performed. Frame-based lead placement took place in an operating room equipped with an MRI machine using stereotactic images to verify lead placement before removing the stereotactic frame. Immediate lead relocation was performed when necessary. Systematic analysis of the targeting error was calculated. RESULTS: Verification of 1201 DBS leads with stereotactic MRI was performed in 643 procedures and with stereotactic CT in 7. The mean ± SD of the final targeting error was 0.9 ± 0.3 mm (range 0.1-2.3 mm). Anatomically acceptable lead placement was achieved with a single brain pass for 97% (n = 1164) of leads; immediate intraoperative relocation was performed in 37 leads (3%) to obtain satisfactory anatomical placement. General anesthesia was used in 91% (n = 593) of the procedures. Hemorrhage was noted after 4 procedures (0.6%); 3 patients (0.4% of procedures) presented with transient neurological symptoms, and 1 experienced delayed cognitive decline. Two bleeds coincided with immediate relocation (2 of 37 leads, 5.4%), which contrasts with hemorrhage in 2 (0.2%) of 1164 leads implanted on the first pass (p = 0.0058). Three patients had transient seizures in the postoperative period. The seizures coincided with hemorrhage in 2 of these patients and with immediate lead relocation in the other. There were 21 infections (3.2% of procedures, 1.5% in 3 months) leading to hardware removal. Delayed (> 3 months) retargeting of 6 leads (0.5%) in 4 patients (0.6% of procedures) was performed because of suboptimal stimulation benefit. There were no MRI-related complications, no permanent motor deficits, and no deaths. CONCLUSIONS: To the authors' knowledge, this is the largest series reporting the use of iMRI to guide and verify lead location during DBS surgery. It demonstrates a high level of accuracy, precision, and safety. Significantly higher hemorrhage was encountered when multiple brain passes were required for lead implantation, although none led to permanent deficit. Meticulous audit and calibration can improve precision and maximize safety.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Rajabian A, Vinke S, Candelario-Mckeown J, et al. Accuracy, precision, and safety of stereotactic, frame-based, intraoperative MRI-guided and MRI-verified deep brain stimulation in 650 consecutive procedures. J Neurosurg. 2022. PMID: 36308483. doi:10.3171/2022.8.JNS22968

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。